Description Of Company
TomoTherapy Inc. had an initial public offering in April 2007 and was acquired by Accuray in 2011. TomoTherapy has developed the Hi-Art treatment system, which combines CT imaging and two flexible radiation delivery modes, TomoHelical and TomoDirect, for highly-precise cancer treatments that help limit radiation exposure to surrounding healthy tissue. The Hi-Art treatment system is the only device developed from the ground up for image-guided, intensity-modulated radiation therapy, and allows a consistent planning and treatment process to be applied to a wide range of cancer cases, with confidence in the results. The technology is used to serve cancer patients on more than 225 systems installed around the world.